Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for acute ischemic stroke recovery (MASTER)
NCT00805792Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of donepezil in ischemic stroke, sponsored by Mayo Clinic. Primary endpoint: Percent of Participants With National Institutes of Health Stroke Scale (NIHSS) Score = 0 or 1 at 90 days. Started Nov 2008; status: completed.
02
Drugs
donepezil
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00805792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00805792.